HAE Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 Apr 2024 @ 10:30):

Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital...

Stats
Today's Volume	59 029.00
Average Volume	487 283
Market Cap	4.53B
EPS	$0 ( 2024-02-08 )
Next earnings date	( $0.880 ) 2024-05-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	36.30
ATR14	$0.235 (0.26%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-15	Lingamneni Anila	Sell	184	Common Stock
2024-03-11	Simon, Christopher	Sell	38 900	Common Stock
2023-11-01	Galvin Roy	Sell	160	Common Stock
2023-10-20	Basil Michelle L	Sell	197	Common Stock
2023-10-20	Strong Stewart W	Sell	120	Common Stock

INSIDER POWER
-12.45
Last 95 transactions
Buy: 406 848 \| Sell: 506 888

Volume Correlation

Long: 0.00 (neutral)

Short: 0.83 (strong)

Signal:(60.963) Same movement expected

Haemonetics Corp Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Haemonetics Corp Correlation - Currency/Commodity

-0.76
( moderate negative )

-0.63
( weak negative )

-0.89
( strong negative )

-0.42
( neutral )

0.08
( neutral )

0.89
( strong )

Haemonetics Corp Financials

Annual	2023
Revenue:	$1.17B
Gross Profit:	$615.10M (52.63 %)
EPS:	$2.27

FY	2023
Revenue:	$1.17B
Gross Profit:	$615.10M (52.63 %)
EPS:	$2.27

FY	2023
Revenue:	$1.17B
Gross Profit:	$615.10M (52.63 %)
EPS:	$0

FY	2022
Revenue:	$993.20M
Gross Profit:	$505.50M (50.90 %)
EPS:	$0.850

Financial Reports:

No articles found.

Haemonetics Corp

Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system. It also provides automated blood component and manual whole blood collection systems, such as MCS brand apheresis equipment to collect specific blood components from the donor; disposable whole blood collection and component storage sets; SafeTrace Tx blood bank information system; and BloodTrack blood management software, a suite of blood management and bedside transfusion solutions that combines software with hardware components, as well as an extension of the hospital's blood bank information system. In addition, the company offers hospital products comprising TEG, ClotPro, and HAS hemostasis analyzer systems that provide a comprehensive assessment of a patient's overall hemostasis; TEG Manager software, which connects various TEG analyzers throughout the hospital, providing clinicians remote access to active and historical test results that inform treatment decisions; and Cell Saver Elite +, an autologous blood recovery system for cardiovascular, orthopedic, trauma, transplant, vascular, obstetrical, and gynecological surgeries. It markets and sells its products through direct sales force, independent distributors, and sales representatives. Haemonetics Corporation was founded in 1971 and is headquartered in Boston, Massachusetts.